Sexually Transmitted Diseases (STDs) and Sexually Transmitted Infections (STIs) continue to be major global public health concerns, affecting millions of people each year and significantly impacting sexual and reproductive health. Common infections include HIV, Human Papillomavirus (HPV), Herpes Simplex Virus (HSV), Chlamydia, Gonorrhea, Syphilis, and Trichomoniasis. Early diagnosis, effective treatment, vaccination, public awareness, and antimicrobial resistance surveillance are essential for reducing disease transmission and improving health outcomes. This track focuses on the latest advances in diagnostics, therapeutics, vaccines, epidemiology, prevention strategies, and public health interventions for STDs and STIs.
Market Analysis: The global sexually transmitted disease (STD/STI) diagnostics and therapeutics market is estimated to be valued at USD 116.4 billion in 2025 and is projected to reach approximately USD 176.8 billion by 2030, growing at a CAGR of 8.7% during the forecast period. Market growth is driven by the rising prevalence of sexually transmitted infections, increasing awareness and screening programs, advancements in molecular diagnostics and point-of-care testing, and expanding vaccination initiatives for HPV and hepatitis. North America continues to dominate the market due to advanced healthcare infrastructure and high screening rates, while the Asia-Pacific region is expected to witness the fastest growth, supported by increasing healthcare investments, public health initiatives, and improved access to diagnostic services.
Share this page on your timeline
ALSO READ Infectious Diseases and Global Health Viral Infections Bacterial Infections Fungal Infections Vector-borne Diseases Virology and HIVAIDS Immunology and Clinical Microbiology Antiviral Drug Resistance Catheter-Associated Urinary Tract Infection Emerging Infectious Diseases Hospital-Acquired Infections HAIs Maternal-Fetal Infections Next-Generation Antibiotics Pediatric Infectious Diseases Sepsis Diagnosis and Care Zoonotic Diseases Neurological and CNS Infections Healthcare-Associated Infections Ophthalmological Infectious Diseases Lower Respiratory and Pediatric IDs Genomics and Infectious disease Special Session on COVID-19 Vaccines and Immunizations Antibiotic Sensitivity Testing Blood-Borne Disease Contagious Disease Encephalitis Global Pandemic Preparedness Influenza Surveillance Systems Microbiome and Immunity Occupational Safety and Health OSH Point-of-Care Testing POCT Travel-Related Infections Tropical Diseases and Parasitic Diseases Sexually Transmitted Diseases and STIs Pathophysiology and Diagnosis Clinical Trials and Case Studies Influencing Factors of IDs Advanced Treatments and Technologies Oral and Maxillofacial Infections Prevention and Control Public Health and Epidemiology Artificial Intelligence in ID Climate Change and Infections Gastroenteritis HIV and Co-Infections Malaria Elimination Strategies Neglected Tropical Diseases NTDs One Health Approach Rapid Diagnostic Innovations Tuberculosis Drug Resistance
Tags
Mycology Conferences
Infectious Diseases Conferences
Epidemiology Conferences
Vector-Borne Diseases Conferences
Public Health Conferences
Infectious Disease Conferences 2026 Asia
Infectious Disease Conferences
Parasitology Conferences
Infection Control Conferences
Infection Conferences 2026 Europe
Infectious Diseases Conferences Europe
Virology Conferences
Infection Conferences 2027 Asia
Entomology Conferences
Microbiology Conferences